# Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment

> **NCT02084420** · PHASE3 · COMPLETED · sponsor: **Il-Yang Pharm. Co., Ltd.** · enrollment: 323 (actual)

## Conditions studied

- Peptic Ulcer

## Interventions

- **DRUG:** Ilaprazole
- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT02084420
- **Lead sponsor:** Il-Yang Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2014-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02084420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02084420, "Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02084420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*